Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00212407 · ClinicalTrials.gov registry record · Early Phase 1
New York Blood Center National Cord Blood Program
A Early Phase 1 study, sponsored by New York Blood Center.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 4,476
- Enrollment target
NCT00212407 is a Early Phase 1 study that was terminated before completion, run by New York Blood Center. The registered enrollment target is 4,476 participants.
The verdict
NCT00212407, a Early Phase 1 study, was terminated before completion, sponsored by New York Blood Center.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 4,476 participants
- Enrollment target
Study Summary
Umbilical cord blood is used as a source of hematopoietic stem cells for bone marrow reconstitution in patients who would be potential candidates for a bone marrow transplant from an unrelated marrow donor. The outcome of transplantation is obtained to assess cord blood myeloid and platelet engraftment, transplant related mortality, overall survival, graft vs. host disease and, for patients with leukemia, lymphoma or myelodysplasia, relapse.
Interventions
- BIOLOGICAL Umbilical Cord Blood Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,476 participants |
| Start Date | 1993-02 |
| Est. Completion | 2011-11-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00212407
The ClinicalTrials.gov registry entry for NCT00212407 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 4,476 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Blood Center, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Umbilical Cord Blood Transplantation is the first listed.
NCT00212407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00212407 about?
NCT00212407 is a clinical study titled "New York Blood Center National Cord Blood Program". Umbilical cord blood is used as a source of hematopoietic stem cells for bone marrow reconstitution in patients who would be potential candidates for a bone marrow transplant from an unrelated marrow donor. The outcome of transplantation is obtained to assess cord blood myeloid and platelet engraftm...
What is the current status of trial NCT00212407?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 4,476 participants. The study started on 1993-02. Estimated completion is 2011-11-10.
What interventions are being tested in trial NCT00212407?
The interventions under investigation include: Umbilical Cord Blood Transplantation (BIOLOGICAL).
Who is sponsoring clinical trial NCT00212407?
This trial is sponsored by New York Blood Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.